<DOC>
	<DOCNO>NCT01926353</DOCNO>
	<brief_summary>Endoscopic correction VUR gain popularity due less invasiveness , associate low morbidity short hospital stay . Although short term follow-up justified efficacy ; however , long term recurrence complication follow endoscopic correction also report literature ( 6 ) . Currently , insufficient evidence efficacy safety biocompatible tissue augment material use endoscopic correction VUR ; particularly new tissue bulking agent . ( 6 ) Polyacrylate polyalcohol copolymer ( PPC ) -Vantris Â® ( Promedon , Cordoba , Argentina ) new tissue augment biocompatible Acrylics use endoscopic correction VUR .</brief_summary>
	<brief_title>Polyacrylate Polyalcohol Copolymer Vesicoureteral Reflux</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Vesico-Ureteral Reflux</mesh_term>
	<criteria>Included patient study 1 3months &gt; 1year posttreatment followup study void cystourethrogram ( VCUG ) , kidney ultrasound , dimercaptosuccinic acid ( DMSA ) renal scan , urine culture . Excluded case patient VUR grade 1 grade 5 , complete followup work ups , concomitant neurogenic bladder , anatomical malformation urinary tract ( obstruction , complete duplicate pelvocaliceal system ) , previous surgical endoscopic procedure , suspect confirmed dysfunctional void clinical finding abnormal result ( irregular bladder wall , diverticulum ) VCUG urodynamic study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Vesicoureteral Reflux ( VUR )</keyword>
	<keyword>Complicated Urinary Tract Infection</keyword>
	<keyword>Vantris</keyword>
	<keyword>Polyacrylate Polyalcohol Copolymer</keyword>
</DOC>